Wealth Effects LLC Lipocine Inc. Transaction History

Wealth Effects LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$0.3 - $0.58 $126,648 - $244,852	-422,160 Reduced 35.81%	756,674 $242,000
Q4 2022 Feb 02, 2023	SELL	$0.37 - $8.65 $13,690 - $320,050	-37,000 Reduced 3.04%	1,178,834 $471,000
Q3 2022 Nov 14, 2022	SELL	$0.49 - $7.65 $129,605 - $2.02 Million	-264,500 Reduced 17.87%	1,215,834 $547,000
Q2 2022 Aug 03, 2022	SELL	$0.73 - $1.34 $7,665 - $14,070	-10,500 Reduced 0.7%	1,480,334 $1.19 Million
Q1 2022 May 16, 2022	BUY	$0.89 - $1.85 $1,246 - $2,590	1,400 Added 0.09%	1,490,834 $2.04 Million
Q4 2021 Feb 09, 2022	BUY	$0.99 - $1.2 $1.47 Million - $1.79 Million	1,489,434 New	1,489,434 $1.48 Million

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $431M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Effects LLC with notifications on news.